1. Ponti G., Maccaferri M., Ruini C. et al. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020; 57 (6): 389-399. https://doi.org/10.1080/10408363.2020.1770685.
2. Tan C., Huang Y., Shi F. et a. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J. Med. Virol. 2020; 92 (7): 856-862. https://doi.org/10.1002/jmv.25871.
3. Gao Y., Li T., Han M. et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 2020; 92 (7): 791-796. https://doi.org/10.1002/jmv.25770.
4. Liu F., Li L., Da Xu M. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J. Clin. Virol. 2020; 127: 104370. https://doi.org/10.1016/j.jcv.2020.104370.
5. Sorayaa G.V., Ulhaq Z.S. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated metaanalysis. Med Clin (Barc.). 2020; 155 (4): 143-151. https://doi.org/10.1016/j.medcli.2020.05.017.
6. Frater J.L., Zini G., d’Onofrio G. et al. COVID-19 and the clinical hematology laboratory. Int. J. Lab. Hematol. 2020; 42 (1): 11-18. https://doi.org/10.1111/ijlh.13229.
7. McGonagle D., Sharif K., O’Regan A. et al. COVID-19 induced pneumonia and macrophage activation syndromelike disease. Autoimmun. Rev. 2020; 19 (6): 102537. https://doi.org/10.1016/j.autrev.2020.102537.
8. Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. 2020; 58 (7): 1131-1134. https://doi.org/10.1515/cclm-2020-0198.
9. Министерство здравоохранения Российской Федерации. Временные методические рекомендации: Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.2020). Доступно на: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_МR_COVID-19_v7.pdf
10. Xie H., Zhao J., Lian N. et al. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study. Liver Int. 2020; 40 (6): 1321-1326. https://doi.org/10.1111/liv.14449.
11. Zhang Ch., Shi L., Wang F.Sh. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020; 5 (5): 428-430. https://doi.org/10.1016/S2468-1253(20)30057-1.
12. Agarwal A., Chen A., Ravindran N. et al. gastrointestinal and liver manifestations of COVID-19. J. Clin. Exp. Hepatol. 2020; 10 (3): 263-265. https://doi.org/10.1016/j.jceh.2020.03.001.
13. Fan Zh., Chen L., Li J. et al. Clinical features of COVID19-related liver functional abnormality. Clin. Gastroenterol. Hepatol. 2020; 18 (7): 1561-1566. https://doi.org/10.1016/j.cgh.2020.04.002.
14. Duan P., Chen Y., Zhang J. et al. Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome. Zhonghua Gan Zang Bing Za Zhi. 2003; 11: 493-496.
15. Cai Q., Huang D., Yu H. et al. COVID-19: Abnormal liver function tests. J. Hepatol. 2020; 73 (3): 566-574. https://doi.org/10.1016/j.jhep.2020.04.006.
16. Garrido I., Liberal R., Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment. Pharmacol. Ther. 2020; 52 (2): 267-275. https://doi.org/10.1111/apt.15813.